Compare IPSC & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | ATLX |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.3M | 105.7M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | ATLX |
|---|---|---|
| Price | $0.99 | $4.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $3.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 669.4K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $113,337,000.00 | $180,454.00 |
| Revenue This Year | $1,590.09 | $22,084.55 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4122.69 | N/A |
| 52 Week Low | $0.34 | $3.54 |
| 52 Week High | $1.19 | $8.25 |
| Indicator | IPSC | ATLX |
|---|---|---|
| Relative Strength Index (RSI) | 71.42 | 43.10 |
| Support Level | $0.93 | $3.70 |
| Resistance Level | $0.62 | $4.94 |
| Average True Range (ATR) | 0.11 | 0.38 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 81.33 | 34.35 |
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.